Maltose interference-free test strips for blood glucose testing at point-of-care: A laboratory performance evaluation

Diabetes Technology and Therapeutics

Volumn 12, Issue 11, 2010, Pages 889-893

  Ng, Wai Yoong ^a   Tiong, Chiau Chiae ^a   Jacob, Edward ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; GLUCOSE; MALTOSE; XYLOSE;

ACCURACY; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CLINICAL EVALUATION; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; POINT OF CARE TESTING; PRIORITY JOURNAL; TEST STRIP;

BLOOD GLUCOSE; GALACTOSE; GLUCOSE DEHYDROGENASES; HEMATOCRIT; HUMANS; MALTOSE; POINT-OF-CARE SYSTEMS; REAGENT STRIPS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; XYLOSE;

EID: 78649336430     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0095     Document Type: Article

References (15)

1. Disse E, Thivolet C: Hypoglycemic coma in a diabetic patient on peritoneal dialysis due to interference of icodextrin metabolites with capillary blood glucose measurements. Diabetes Care 2004;27:2279.
2. U.S. Food and Drug Administration: FDA Public Health Notification: Potentially Fatal Errors with GDH-PQQ Glucose Monitoring Technology. www.fda.gov/Medical Devices/Safety/AlertsandNotices/PublicHealthNotifications/ ucm176992.htm (accessed February 2010).
3. nd ed. CLSI document EP15-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2005.
4. Martin RF: General Deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clin Chem 2000;46:100-104.
5. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.
6. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
7. International Organization for Standardization: In Vitro Diagnostic Test Systems\Requirements for Blood-Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus. International Standard. Report number ISO 15197:2003(E). Geneva: International Organization for Standardization, 2003.
8. Chesher D: Evaluating assay precision. Clin Biochem Rev 2008;29(Suppl):S23-S26.
9. Florkowski C, Budgen C, Kendall D, Lunt H, Moore P: Comparison of blood glucose meters in a New Zealand diabetes centre. Ann Clin Biochem 2009;46:302-305.
10. nd ed. NCCLS document C30-A2. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
11. U.S. Food and Drug Administration: Total Product Life Cycle for Portable Invasive Blood Glucose Monitoring Systems (Draft Guidance for Industry and FDA Staff). www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm079138.htm#5 (accessed July 2010).
12. American Diabetes Association: Self-monitoring of blood glucose. Diabetes Care 1996;19(Suppl 1):S62-S66.
13. Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, Reynolds R, Ogrinc F, Martis L, Wolfson M: Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002;(81):S23-S33.
14. Posthuma N, ter Weel P, Donker A, Peers E, Oe P, Verbrugh H: Icodextrin use in CCPD patients during peritonitis: ul-trafiltration and serum disaccharide concentrations. Nephrol Dial Transplant 1998;13:2341-2344.
15. Schleis TG: Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Phar-macotherapy 2007;27:1313-1321.